Dealing with the gray zones in the management of gastric cancer: The consensus statement of the Istanbul Group


AYTAÇ E., Aslan F., ÇİÇEK B., Erdamar S., Gurses B., GÜVEN K., ...Daha Fazla

TURKISH JOURNAL OF GASTROENTEROLOGY, cilt.30, sa.7, ss.584-598, 2019 (SCI-Expanded) identifier identifier identifier

  • Yayın Türü: Makale / Derleme
  • Cilt numarası: 30 Sayı: 7
  • Basım Tarihi: 2019
  • Doi Numarası: 10.5152/tjg.2018.18737
  • Dergi Adı: TURKISH JOURNAL OF GASTROENTEROLOGY
  • Derginin Tarandığı İndeksler: Science Citation Index Expanded (SCI-EXPANDED), Scopus, TR DİZİN (ULAKBİM)
  • Sayfa Sayıları: ss.584-598
  • Anahtar Kelimeler: Gastric cancer, neoadjuvant treatment, adjuvant treatment, staging, surgical treatment, LYMPH-NODE DISSECTION, CLINICAL-PRACTICE GUIDELINES, PHASE-III TRIAL, SIEWERT TYPE-II, PERIOPERATIVE CHEMOTHERAPY, NEOADJUVANT CHEMOTHERAPY, GASTROINTESTINAL CANCER, GASTROESOPHAGEAL ADENOCARCINOMA, PREOPERATIVE CHEMORADIOTHERAPY, PROGNOSTIC-SIGNIFICANCE
  • İstanbul Üniversitesi Adresli: Evet

Özet

The geographical location and differences in tumor biology significantly change the management of gastric cancer. The prevalence of gastric cancer ranks fifth and sixth among men and women, respectively, in Turkey. The international guidelines from the Eastern and Western countries fail to manage a considerable amount of inconclusive issues in the management of gastric cancer. The uncertainties lead to significant heterogeneities in clinical practice, lack of homogeneous data collection, and subsequently, diverse outcomes.